Clostridium
species have gained attention in industrial and medical applications, and the development of genetic tools has enabled the advancement of the CRISPR-Cas systems for these bacteria. Compared to the primarily used Cas9 from
Streptococcus pyogenes
, the utilization of Cas12a (previously known as Cpf1) proteins remains incomplete in clostridia, although they exhibit potential advantages, including T-rich recognition for
Clostridium
genomes and lower toxicity. In this study, we expanded the CRISPR-Cas tools in clostridia by establishing a CRISPR-Cas12a system with two different
cas12a
genes (
Ascas12a
from
Acidaminococcus
and
Fncas12a
from
Francisella novicida
). The optimized tetracycline-inducible systems were initially determined by the glucuronidase reporter and were used to drive expression of the
cas12a
genes and crRNAs. Our results demonstrate that the CRISPR-FnCas12a system offers flexible target selection in clostridia, and a specific folding pattern of the precursor crRNA is important to enable high mutation generation efficiency. By using
sacB
(encoding levansucrase) as a negative marker for plasmid curing and determining the optimal size of the donor DNA template for gene integration in the CRISPR-FnCas12a system, we achieved highly efficient and rapid genome modification, exemplified by the successful engineering of clostridia (
Clostridium butyricum
and
Clostridium sporogenes
) to produce near-infrared fluorescence from biliverdin and hemin.
IMPORTANCE
Continued efforts in developing the CRISPR-Cas systems will further enhance our understanding and utilization of
Clostridium
species. This study demonstrates the development and application of a genome-engineering tool in two
Clostridium
strains,
Clostridium butyricum
and
Clostridium sporogenes
, which have promising potential as probiotics and oncolytic agents. Particular attention was given to the folding of precursor crRNA and the role of this process in off-target DNA cleavage by Cas12a. The results provide the guidelines necessary for efficient genome engineering using this system in clostridia. Our findings not only expand our fundamental understanding of genome-engineering tools in clostridia but also improve this technology to allow use of its full potential in a plethora of biotechnological applications.